United States · FDA National Drug Code directory
Bimzelx
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50474-783_37b310bd-f6a0-9d4e-e063-6294a90a889d
- Product NDC
- 50474-783
- Form
- INJECTION, SOLUTION
- Composition / generic term
- bimekizumab
- Labeler
- UCB, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20241205
- Source listing expiry
- 20261231
Source-listed ingredients
- BIMEKIZUMAB — 320 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (50474-783-78) / 2 mL in 1 SYRINGE, GLASS · 50474-783-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →